Initiating Peritoneal Dialysis After Catheter Insertion Initiating Peritoneal Dialysis After Catheter Insertion
Dr Desai discusses the uncertainty that remains about commencement of dialysis after catheter insertion.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2017 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news
Kenya: Medics Urge State to Expand NHIF Cover for Kidney Treatment
[Nation] Medics want the National Hospital Insurance Fund (NHIF) cover to be expanded to cater for both peritoneal dialysis as well as post-transplant care of kidney patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 27, 2017 Category: African Health Source Type: news
7 medtech stories we missed this week: Sept. 15, 2017
[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention.
1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial
Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for woun...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Dental Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Surgical Acera Surgical Contego Medical Fresenius MedTech OBP Medical Pinnacle Sciences Plusoptix Telos Source Type: news
Baxter inks tech transfer deal for surgical devices out of Tel Aviv University
Baxter‘s (NYSE:BAX) said today it inked a licensing agreement with Tel Aviv University’s Ramot business engagement center through which the company aims to bring early stage research technologies in development at the university to the market.
As part of the agreement, Baxter said it will gain an exclusive license for the TAU Technology Innovation Momentum Fund tech in 1 license agreement and TAU and Tel Aviv Sourasky Medical Center tech in a 2nd.
“Baxter is committed to finding creative pathways to bring innovative solutions to the operating room. By working with leading experts at TAU and TASMC, we have ac...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Baxter Source Type: news
Local amplifiers of IL-4R{alpha}-mediated macrophage activation promote repair in lung and liver
The type 2 immune response controls helminth infection and maintains tissue homeostasis but can lead to allergy and fibrosis if not adequately regulated. We have discovered local tissue-specific amplifiers of type 2–mediated macrophage activation. In the lung, surfactant protein A (SP-A) enhanced interleukin-4 (IL-4)–dependent macrophage proliferation and activation, accelerating parasite clearance and reducing pulmonary injury after infection with a lung-migrating helminth. In the peritoneal cavity and liver, C1q enhancement of type 2 macrophage activation was required for liver repair after bacterial infectio...
Source: ScienceNOW - June 8, 2017 Category: Science Authors: Minutti, C. M., Jackson-Jones, L. H., Garcia-Fojeda, B., Knipper, J. A., Sutherland, T. E., Logan, N., Rinqvist, E., Guillamat-Prats, R., Ferenbach, D. A., Artigas, A., Stamme, C., Chroneos, Z. C., Zaiss, D. M., Casals, C., Allen, J. E. Tags: Immunology reports Source Type: news
Baxter touts Sharesource in-home peritoneal dialysis patient monitoring study data
Baxter (NYSE:BAX) today released data from multiple studies of its Sharesource remote patient monitoring technology used for peritoneal dialysis patient care.
Data from the study was presented at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this week.
Sharesource is a 2-way cloud-based technology offered with the company’s Homechoice Claria automated PD system to allow providers to connect with patients using the device and verify patient adherence, the company said.
Data from the 1st study study, which included 399 APD patients using remote patient man...
Source: Mass Device - June 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Patient Monitoring Baxter Source Type: news
Baxter inks R & D deal with Mayo Clinic, initial focus on kidney disease
Baxter (NYSE:BAX) said today that it inked a research & development collaborative deal with the Mayo Clinic to develop new technologies and therapies designed to improve patient therapeutic care.
The pair will initially focus on kidney disease, with additional projects planned in other areas where breakthrough treatment options can be introduced and innovation can improve access to high-quality care.
“We are excited about combining Mayo’s clinical and research expertise with Baxter’s ability to apply and scale innovation. We are confident that this collaboration will help accelerate discoveries, development ...
Source: Mass Device - May 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Baxter Source Type: news
DaVita buys Delafield dialysis clinic operator
DaVita Kidney Care said Monday that it has purchased a Delafield operator of dialysis clinics less than one week after reporting a tough quarter and two other acquisitions.
DaVita Kidney Care, a division of Denver-based DaVita Inc. (NYSE: DVA), acquired Purity Dialysis, which has 10 centers in the Milwaukee area. Purity Dialysis clinics also provide outpatient hemodialysis and in-home peritoneal dialysis training.
Terms of the deal were not disclosed.
DaVita operat es about a dozen clinics in Milwaukee… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2017 Category: Pharmaceuticals Authors: Caitlin Hendee Source Type: news
DaVita scoops up Wisconsin operator of dialysis clinics
DaVita Kidney Care announced Monday that it has scooped up a Wisconsin operator of 10 dialysis clinics less than one week after reporting a tough quarter and two other acquisitions.
DaVita Kidney Care, a division of Denver-based DaVita Inc. (NYSE: DVA), acquired Purity Dialysis, which has 10 centeres in the greater Milwaukee area. Purity Dialysis clinics also provide out-patient hemodialysis and in-home peritoneal dialysis training.
Terms of the deal were not disclosed.
"We look forward to providing… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 8, 2017 Category: American Health Authors: Caitlin Hendee Source Type: news
Baxter looks to combination device pathway for home peritoneal dialysis machine
Baxter (NYSE:BAX) said today that after communicating with the FDA, it will pursue a regulatory pathway as a combination product for its new home peritoneal dialysis solution system.
The system is desigend to produce sterile PD solutions using a small water filtration device designed to be placed in a patient’s home and integrated into its AMIA automated peritoneal dialsysis system, the Deerfield, Ill.-based company said.
“The FDA’s guidance is a pivotal milestone in advancing our new system forward for use by renal patients in an expedient manner. These technology advancements have the potential to greatly ...
Source: Mass Device - May 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Baxter Source Type: news
Peritoneal Dialysis Safe for Post-Op Fluid Overload in Infants with CHD
(MedPage Today) -- Diuretics linked to higher risk of prolonged ventilation (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 21, 2017 Category: Surgery Source Type: news
Myths in Peritoneal Dialysis Myths in Peritoneal Dialysis
Common misperceptions about peritoneal dialysis may influence the practices of this therapy. Find out what they are.Current Opinion in Nephrology and Hypertension (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
New method makes peritoneal dialysis more tolerable
The addition of a new type of fluid for use in peritoneal dialysis makes it easier to tolerate and protects the cells in the abdominal cavity. This could make the peritoneum more resilient to harmful effects, report investigators. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 22, 2016 Category: Science Source Type: news
Baxter touts data on home peritoneal dialysis
Baxter (NYSE:BAX) today released data on its Sharesource remote patient monitoring and home-use Amia automated peritonial dialysis systems, touting its ability to improve early detection of adverse issue issues and faster treatment.
Data on the platforms was presented at the American Society of Nephrology’s annual Kidney Week meeting last week in Chicago.
Data from a case study of Baxter’s Sharesource indicated that the system was able to identify a displaced catheter through an early alert and diagnosis, which was surgically repositioned, the company said.
A simulation study of 12 APD patient profiles indicat...
Source: Mass Device - November 21, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Clinical Trials Patient Monitoring Baxter Source Type: news
Extraneal (Icodextrin Peritoneal Dialysis Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news
